Expression of the First Recombinant Anti-Tumoral Snake Venom Kunitz-Type Serine Protease Inhibitor
PIVL is a Kunitz-type serine protease inhibitor that was previously characterized from Tunisian snake venom, <i>Macrovipera lebetina transmediterranea</i>. It reduced glioblastoma cells’ development and significantly blocked angiogenesis in in-vitro and ex-vivo models. PIVL exerted these...
Main Authors: | Maram Morjen, Wassim Moslah, Imen Touihri-Baraketi, Najet Srairi-Abid, José Luis, Naziha Marrakchi, Jed Jebali |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Toxins |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6651/14/3/170 |
Similar Items
-
CC5 and CC8, Two Disintegrin Isoforms from <i>Cerastes cerastes</i> Snake Venom Decreased Inflammation Response In Vitro and In Vivo
by: Maram Morjen, et al.
Published: (2023-08-01) -
Effect of thermally untreated soybean with low levels of Kunitz trypsin inhibitors in the diet of broilers
by: Beuković Dejan, et al.
Published: (2011-01-01) -
The Procoagulant Snake Venom Serine Protease Potentially Having a Dual, Blood Coagulation Factor V and X-Activating Activity
by: Zorica Latinović, et al.
Published: (2020-05-01) -
The First Anti-Snakebite and Hepatoprotective Characterization of a Trypsin Kunitz-like Inhibitor (EcTI) from the Plant <i>Enterolobium contortisiliquum;</i> A Case of Two Soul Mates Meeting
by: Caroline R. C. Costa, et al.
Published: (2023-04-01) -
Exploring the Utility of Recombinant Snake Venom Serine Protease Toxins as Immunogens for Generating Experimental Snakebite Antivenoms
by: Nessrin Alomran, et al.
Published: (2022-06-01)